Acamprosate has been commercially available in the USA since 2004 to treat alcohol
dependence. Its safety and efficacy have been demonstrated in a number of clinical trials …

Importance to the field: Acamprosate, marketed under the brand name Campral®,(Forest
Pharmaceuticals, Inc., Saint Louis, MO, USA; Merck Sante sas, Lyon, France) is an orally …

Alcohol dependence is a chronic, relapsing disorder affecting more than 8 million Americans
who are at increased risk for negative interpersonal and health consequences from …

Acamprosate, a medication that has been used in Europe for years, is the newest drug to be
approved by the US Federal Drug Administration for the treatment of alcohol dependence. It …

Acamprosate is indicated for the maintenance of abstinence from alcohol in patients with
alcohol dependence who are abstinent at treatment initiation in combination with …

Acamprosate, or N-acetyl homotaurine, is an N-methyl-D-aspartate receptor modulator
approved by the Food and Drug Administration (FDA) as a pharmacological treatment for …

Acamprosate (calcium acetyl-homotaurine) is a synthetic compound that crosses the blood-
brain barrier and has a chemical structure similar to that of the naturally occurring amino …

BACKGROUND:: Both inpatient and outpatient treatment centers that focus solely on
psychosocial therapies for the treatment of alcohol dependence have high relapse rates …

Acamprosate (Campral® delayed-release tablet), a synthetic compound with a similar
structure to that of the neurotransmitter GABA and the neuromodulator taurine, facilitates the …

Alcoholism is one of the most prevalent substance dependence disorders in the world.
Advances in research in the neurobiological mechanisms underlying alcohol dependence …